Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;67(6):1565-1572.
doi: 10.1109/TBME.2019.2940195. Epub 2019 Sep 9.

Prediction of Upstaged Ductal Carcinoma In Situ Using Forced Labeling and Domain Adaptation

Prediction of Upstaged Ductal Carcinoma In Situ Using Forced Labeling and Domain Adaptation

Rui Hou et al. IEEE Trans Biomed Eng. 2020 Jun.

Abstract

Objective: The goal of this study is to use adjunctive classes to improve a predictive model whose performance is limited by the common problems of small numbers of primary cases, high feature dimensionality, and poor class separability. Specifically, our clinical task is to use mammographic features to predict whether ductal carcinoma in situ (DCIS) identified at needle core biopsy will be later upstaged or shown to contain invasive breast cancer.

Methods: To improve the prediction of pure DCIS (negative) versus upstaged DCIS (positive) cases, this study considers the adjunctive roles of two related classes: atypical ductal hyperplasia (ADH), a non-cancer type of breast abnormity, and invasive ductal carcinoma (IDC), with 113 computer vision based mammographic features extracted from each case. To improve the baseline Model A's classification of pure vs. upstaged DCIS, we designed three different strategies (Models B, C, D) with different ways of embedding features or inputs.

Results: Based on ROC analysis, the baseline Model A performed with AUC of 0.614 (95% CI, 0.496-0.733). All three new models performed better than the baseline, with domain adaptation (Model D) performing the best with an AUC of 0.697 (95% CI, 0.595-0.797).

Conclusion: We improved the prediction performance of DCIS upstaging by embedding two related pathology classes in different training phases.

Significance: The three new strategies of embedding related class data all outperformed the baseline model, thus demonstrating not only feature similarities among these different classes, but also the potential for improving classification by using other related classes.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Illustration of different pathology classes associated with breast cancer. ADH is benign but at high risk for being associated with cancer, DCIS is stage-0 cancer still confined within the milk duct, while IDC has invaded beyond the duct and can metastasize to lymph nodes or further.
Fig. 2.
Fig. 2.
Illustration of the Pipeline in Extraction MCs from Mammograms. First, the lesion ROI from original mammogram was annotated by a breast radiologist; Second, we applied some image enhancement algorithms to enhance the detectability of MCs; Third, MCs within the lesion ROI was detected; Last 113 features were extracted from both individual MCs and MC clusters.
Fig. 3.
Fig. 3.
Illustration of Four Models Designed with Traditional Way and Embedding ADH and IDC in Training
Fig. 4.
Fig. 4.
AUC of adding either ADH or IDC cases for training the classifier.
Fig. 5.
Fig. 5.
Heat-map of adding different number of ADH and IDC to training phase.
Fig. 6.
Fig. 6.
ROC Curves showing classification performances of different models: traditional classifier, forced labeling and domain adaptation.
Fig. 7.
Fig. 7.
Precision-Recall Curves showing classification performances of different models: traditional classifier, forced labeling and domain adaptation.
Fig. 8.
Fig. 8.
The Top Ranked Feature’s Distributions of Four Classes.

Similar articles

Cited by

References

    1. Ali SZ, Surveillance of BIRADS 3 lesions. Breast J, 2017. 23(5): p. 617. - PubMed
    1. Brinton LA, et al., Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst, 2008. 100(22): p. 1643–8. - PMC - PubMed
    1. Virnig BA, et al., Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. Journal of the National Cancer Institute, 2010. 102(3): p. 170–178. - PubMed
    1. Sanders ME, et al., The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer, 2005. 103(12): p. 2481–4. - PubMed
    1. Collins LC, et al., Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer, 2005. 103(9): p. 1778–84. - PubMed

Publication types